Tesamorelin – 10mg

It contains a trans 3 hexenoic acid modification at the N terminus, extending its biological half life and improving resistance to enzymatic degradation. These structural
modifications make it a valuable compound for research involving endocrine signaling, growth hormone regulation, and lipid metabolism.
In in vitro and in vivo experimental models, Tesamorelin has been evaluated for its activity across multiple endocrine and metabolic pathways, including:
• GHRH Receptor Activation and Signal Transduction – examined for peptide receptor
interactions and cyclic AMP mediated growth hormone secretion pathways
• Endocrine and Metabolic Regulation – investigated for modulation of the GH IGF 1 axis and
downstream effects on lipolysis, glucose metabolism, and insulin signaling dynamics
• Molecular Stability and Pharmacokinetic Properties – studied for enhanced resistance to
enzymatic breakdown and sustained receptor activation
This compound continues to be utilized in mechanistic research exploring GHRH receptor
pharmacodynamics, metabolic regulation processes, and peptide engineering strategies related
to endocrine modulation.